The U.S. Food and Drug Administration (FDA) has added a so-called “black box” (“boxed warning”) alert to the multiple sclerosis drug Copaxone (glatiramer acetate) and its generic version, Glatopa, because of rare but potentially fatal allergic...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.